Downregulation of DNM2 has been shown to efficiently rescue the phenotypes of mouse models for MTM1, BIN1- and DNM2-related CNM, representing a potential common therapy for several CNM forms (35, 40, 41). This evidence concerns the gene MTM1 and centronuclear myopathy.